Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.83 |
| ▸ | ESR1 | P03372 | 5/20 | 0.83 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.83 |
| ▸ | CACNA1H | O95180 | 3/20 | 0.83 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.83 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.83 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.83 |
| ▸ | MAOA | P21397 | 1/20 | 0.83 |
| ▸ | PDE5A | O76074 | 1/20 | 0.83 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.75 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.68 |
| ▸ | PRKCA | P17252 | 1/20 | 0.68 |
| ▸ | BACE1 | P56817 | 1/20 | 0.68 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glabranin SCHEMBL320135 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Sophoraflavanone B SCHEMBL147316 | 0.91 | ESR1 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Sophoraflavanone B SCHEMBL29396586 | 0.91 | ESR1 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Sophoraflavanone B SCHEMBL1171435 | 0.91 | ESR1 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Sophoraflavanone B SCHEMBL14304885 | 0.91 | ESR1 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Sophoraflavanone B SCHEMBL1931652 | 0.90 | ESR1 (0.98) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| SCHEMBL29895534 | 0.88 | CYP3A4 (0.79) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| SCHEMBL1170921 | 0.88 | PTPN1 (0.84) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| SCHEMBL24075554 | 0.86 | MAPT (0.83) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 | |
| Lespedezaflavanone B SCHEMBL1171210 | 0.86 | PTPN1 (1.00) | CYP3A4CYP2D6CYP2C9ACHECYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240373850-A1 | Compositions comprising resinous exudate metabolites from plants of the genus Adesmia, used to control and treat infections in plant crops; and methods for controlling infections in plant crops. | PONTIFICIA UNIV CATOLICA DE VALPARAISO (CL) | 2024-11-14 | — | — | US | claimed |
| WO-2022221968-A1 | COMPOSITIONS COMPRISING RESINOUS EXUDATE METABOLITES FROM PLANTS OF THE GENUS ADESMIA, USED TO CONTROL AND TREAT INFECTIONS IN PLANT CROPS; AND METHODS FOR CONTROLLING INFECTIONS IN PLANT CROPS | PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO (CL) | 2022-10-27 | — | — | WO | claimed |
| CN-114245826-A | Method for producing strictoside and monoterpene indole alkaloid | 丹麦科技大学 | 2022-03-25 | — | — | CN | claimed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | claimed |
| CN-112135829-A | Method and apparatus for preparing terpene indole alkaloid | 约翰·英尼斯中心 | 2020-12-25 | — | — | CN | claimed |
| CN-111714489-A | Double-topoisomerase inhibitor with tumor killing effect and preparation method thereof | 德萌达生物医药科技(杭州)有限公司 | 2020-09-29 | — | — | CN | claimed |
| EP-2858641-B1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORP (US) | 2017-09-06 | — | — | EP | claimed |
| CN-106728142-A | A kind of pharmaceutical composition for treating optic atrophy | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106727859-A | It is a kind of to treat pharmaceutical composition of pharyngitis and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106727877-A | It is a kind of to treat pharmaceutical composition of periodontitis and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2015-05-21 | — | — | US | claimed |
| EP-2858641-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF Corporation (US) | 2015-04-15 | — | — | EP | claimed |
| WO-2013184884-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORPORATION (US) | 2013-12-12 | — | — | WO | claimed |
| EP-2590624-A1 | USE OF GLABRANIN FOR STIMULATING HAIR GROWTH | Unilever PLC (GB) | 2013-05-15 | — | — | EP | claimed |
| US-20130096189-A1 | USE OF GLABRANIN FOR STIMULATING HAIR GROWTH | CONOPCO, INC., D/B/A UNILEVER | 2013-04-18 | — | — | US | claimed |
| CN-102985065-A | Use of glabranin for stimulating hair growth | UNILEVER PL | 2013-03-20 | — | — | CN | claimed |
| WO-2012004228-A1 | USE OF GLABRANIN FOR STIMULATING HAIR GROWTH | UNILEVER PLC (GB) | 2012-01-12 | — | — | WO | claimed |
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | CAVALIER DISCOVERY | 2003-05-01 | — | — | US | claimed |
| WO-2002100478-A9 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2003-03-27 | — | — | WO | claimed |
| WO-2002100478-A2 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2002-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | CYP3A4 3724/4885CYP2D6 3555/4885CYP2C9 2132/4885 |
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | SOD1, SOD3, APEX1 | CYP3A4 1097/4885CYP2D6 762/4885CYP2C9 2785/4885 |
| US-20130096189-A1 | USE OF GLABRANIN FOR STIMULATING HAIR GROWTH | GALR2, GALR1, GALR3 | CYP3A4 4524/4885CYP2D6 3533/4885CYP2C9 3016/4885 |
| US-20240373850-A1 | Compositions comprising resinous exudate metabolites from plants of the genus Adesmia, used to control and treat infections in plant crops; and methods for controlling infections in plant crops. | ERG28, RXFP4, CROCC | CYP3A4 1006/4885CYP2D6 1060/4885CYP2C9 2998/4885 |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | ALG1, ALG8, CUTA | CYP3A4 3724/4885CYP2D6 3555/4885CYP2C9 2132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.